Dyrk1A-IN-5（Cat No.:I043559）is a selective inhibitor of DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A), a kinase implicated in various neurological disorders, including Alzheimer’s disease and Down syndrome. By inhibiting DYRK1A activity, Dyrk1A-IN-5 has shown potential in regulating key cellular processes like neurogenesis, synaptic plasticity, and tau phosphorylation. Research suggests that Dyrk1A-IN-5 may help mitigate cognitive deficits associated with these disorders. Its specificity and potency make it a promising candidate for further investigation as a therapeutic agent, especially in the development of treatments targeting neurodegenerative diseases and other related conditions.